ReCross – When Two Worlds Meet
Published: 18 May 2021
-
Views:
10192
-
Likes:
7
-
Views:
10192
-
Likes:
7
-
Up Next
-
2m 20s
-
2m 57s
-
2m 29s
-
2m 7s
-
47s
-
19m 56sPart 2 | Session 12 My personal experience of ReCross versatility: Dr Garbo (19mins 56secs)
-
8m 19s
-
21m 11sPart 3 | Session 1 ReCross within my CTO algorithm: Dr McEntegart (21mins 11secs)
-
1m 31s
-
5m 23s
-
20m 9s
-
8m 58s
-
2m 55sPart 1 | Session 1 How-to-use ReCross video Dr Avran (2mins 55secs) Farouc Jaffer, Alexandre Avran, Andrew Lucking, Emmanouil S Brilakis, Elliot Smith, Roberto Garbo, Ajay J Kirtane, Margaret McEntegart, Gabriele Gasparini
-
4m 12sPart 1 | Session 2 Official IMDS ReCross How-to-Use Video (4mins 12secs)
-
16m 46sPart 1 | Session 3 How ReCross Modified My CTO Strategies: Dr Avran (16mins 46secs) Farouc Jaffer, Alexandre Avran, Andrew Lucking
-
20m 52sPart 1 | Session 4 ReCross ADR experience and “Real World” versatility: Dr Lucking (20mins 52secs) Farouc Jaffer, Andrew Lucking
-
2m 12sPart 1 | Session 5 Exit port orientation- easy tips: Dr Lucking (2mins 12secs) Alexandre Avran, Andrew Lucking
-
6m 59sPart 1 | Session 6 Practical insights for ReCross use: Drs Jaffer and Avran (6mins 59secs) Farouc Jaffer
-
7m 29sPart 1 | Session 7 Summary of ReCross versatility in ADR summary (7mins 29secs) Farouc Jaffer, Alexandre Avran, Andrew Lucking
-
39sPart 2 | Session 1 ReCross changes the way we think about CTO interventions: Dr Brilakis (39secs) Emmanouil S Brilakis
-
2m 31sPart 2 | Session 2 Familiarisation with ReCross microcatheter functionality: Dr Smith (2mins 31secs) Elliot Smith
-
21m 31sPart 2 | Session 3 Clinical ADR experience with ReCross in CTO PCI: Dr Smith (21mins 31secs) Elliot Smith
-
6m 53sPart 2 | Session 4 Discussion and questions from the audience : Drs Brilakis, Smith & Garbo (6mins 53secs) Emmanouil S Brilakis, Elliot Smith, Roberto Garbo
-
1m 10sPart 2 | Session 5 Summary of how ReCross has improved my antegrade success: Dr Garbo (1min 10secs) Roberto Garbo
Overview
Through the case experience of an international faculty of CTO PCI experts, the emerging understanding of the everyday efficiency of the unique ReCross dual OTW lumen microcatheter is demonstrated.
The experts consider their personal CTO PCI algorithms, and how they believe ReCross’s versatility allows the device to contribute to antegrade success in the widely recognised EuroCTO Club and Hybrid algorithms respectively.
![Sponsor](https://assets.radcliffecardiology.com/s3fs-public/video-series/2021-07/IMDS%20ReCross.png)
Key Learning Objectives
- Understand the versatility of the unique ReCross dual OTW microcatheter in CTO PCI
- Discover, via case demonstrations, how the ReCross device creates a bridge between commonly used CTO PCI algorithms, for example EuroCTO and Hybrid
- Learn from CTO PCI experts how, in their experience, there is a potential to increase antegrade success rates with this device
- Learn how the accessible versatility of ReCross has the potential role for operators expanding their skill set from Antegrade Wire Escalation to parallel wiring and ADR
Faculty
- Dr Farouc Jaffer
- Dr Alexandre Avran
- Dr Andrew Lucking
- Dr Emmanouil Brilakis
- Dr Elliot Smith
- Dr Roberto Garbo
- Dr Ajay Kirtane
- Dr Margaret McEntegart
- Dr Gabriele Gasparini
More from this programme
Part 1
When Two Worlds Meet 1
Part 2
When Two Worlds Meet 2
Part 3
When Two Worlds Meet 3
Faculty Biographies
![Roberto Garbo](https://assets.radcliffecardiology.com/s3fs-public/author/2024-05/Dr%20Garbo%2C%20Roberto.png?VersionId=QX7rAiD34KME.jguq2dN7505ZwGp3_VI)
Roberto Garbo
Interventional Cardiologist
Dr Roberto Garbo is an Interventional Cardiologist at Maria Pia Hospital, Turin, IT. He has been an Interventional Cardiologist since 1999.
He was Head of the Cath Lab at San Giovanni Bosco Hospital from 2005- 2020, director of the CTO PCI, CHIP and complex PCI programmes over the last 15 years.
He has operated more than 2,200 CTO PCI, of which 1,100 with retrograde approach.
Proctor for CTO PCI programmes in Italy, Europe (France, Poland, Romania, Czeck Republic, Russia) and Middle East (Egypt, Saudi Arabia).